Home/Filings/3/0000950170-25-082489

3//SEC Filing

Revelation Alpine, LLC 3

Accession 0000950170-25-082489

CIK 0001611115other

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:08 PM ET

Size

30.9 KB

Accession

0000950170-25-082489

Insider Transaction Report

Form 3

Period: 2025-06-05

Omada Health, Inc.OMDA

Revelation Alpine, LLC

10% Owner

Holdings

Common Stock
(indirect: See footnotes)
23,664
Common Stock
(indirect: See footnotes)
656,041
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Common Stock
(indirect: See footnotes)
346,665
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)

REVELATION ALPINE, L.P.

10% Owner

Holdings

Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Common Stock
(indirect: See footnotes)
23,664
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Common Stock
(indirect: See footnotes)
656,041
Common Stock
(indirect: See footnotes)
346,665
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)

Revelation Healthcare Fund IV, L.P.

10% Owner

Holdings

Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Common Stock
(indirect: See footnotes)
346,665
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Common Stock
(indirect: See footnotes)
23,664
Common Stock
(indirect: See footnotes)
656,041
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)

Revelation Alpine GP, LLC

10% Owner

Holdings

Common Stock
(indirect: See footnotes)
23,664
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Common Stock
(indirect: See footnotes)
346,665
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Common Stock
(indirect: See footnotes)
656,041
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)

Revelation Healthcare Fund II GP, L.P.

10% Owner

Holdings

Common Stock
(indirect: See footnotes)
23,664
Common Stock
(indirect: See footnotes)
346,665
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Common Stock
(indirect: See footnotes)
656,041
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Healthcare Fund IV GP, L.P.

10% Owner

Holdings

Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Common Stock
(indirect: See footnotes)
346,665
Common Stock
(indirect: See footnotes)
656,041
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Common Stock
(indirect: See footnotes)
23,664
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)

REVELATION HEALTHCARE FUND II, L.P.

10% Owner

Holdings

Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Common Stock
(indirect: See footnotes)
346,665
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Common Stock
(indirect: See footnotes)
23,664
Common Stock
(indirect: See footnotes)
656,041
Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Healthcare Fund II GP, LLC

10% Owner

Holdings

Common Stock
(indirect: See footnotes)
346,665
Common Stock
(indirect: See footnotes)
656,041
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Common Stock
(indirect: See footnotes)
23,664
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)

Revelation Healthcare Fund IV GP, LLC

10% Owner

Holdings

Series C-1 Preferred Stock
(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Series D Preferred Stock
(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Common Stock
(indirect: See footnotes)
23,664
Common Stock
(indirect: See footnotes)
346,665
Common Stock
(indirect: See footnotes)
656,041
Series C Preferred Stock
(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Series E Preferred Stock
(indirect: See footnotes)
→ Common Stock (278,000 underlying)

Footnotes (8)

[F1]Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
[F2]Shares held by Revelation Alpine, LLC.
[F3]Shares held by Revelation Healthcare Fund II, L.P.
[F4]Shares held by Revelation Healthcare Fund IV, L.P.
[F5]Shares held by Revelation Alpine, L.P.
[F6]Revelation Healthcare Fund II GP, LLC is the general partner of Revelation Healthcare Fund II GP, L.P., which is the general partner of Revelation Healthcare Fund II, L.P. Revelation Alpine GP, LLC is the general partner of Revelation Alpine, L.P. and the manager of Revelation Alpine, LLC. Revelation Healthcare Fund IV GP, LLC is the general partner of Revelation Healthcare Fund IV GP, L.P., which is the general partner of Revelation Healthcare Fund IV, L.P. Scott Halsted and Michael Boggs are the managing members of Revelation Healthcare Fund II GP, LLC, Revelation Alpine GP, LLC, and Revelation Healthcare Fund IV GP, LLC and in such capacity make investment and voting decisions on behalf of Revelation Alpine, LLC, Revelation Healthcare Fund II, L.P., Revelation Healthcare Fund IV, L.P. and Revelation Alpine, L.P.
[F7]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act or for any other purpose.
[F8]Each share of Series C Preferred Stock, Series C-1 Preferred Stock, Series D Preferred Stock and Series E Preferred Stock is convertible into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering after giving effect to the 1-for-3 reverse split of the Issuer's common stock effected on May 27, 2025. These shares are reported in Table II above on an as-converted basis and have no expiration date.

Documents

1 file

3
ownership.xmlPrimary
3

Issuer

Omada Health, Inc.

CIK 0001611115

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001910436

Filing Metadata

Form type: 3
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 5:08 PM ET
Size: 30.9 KB

View on SEC.gov